Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05910_nanopub.RAJTBc5XobmXDWvtaRFnsSmZM4KTEGGCqQJUScX_Nzzqc#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05910 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05910 label "ALS-357 [drugbank:DB05910]" assertion.
- drugbank:DB05910 seeAlso DB05910 assertion.
- drugbank:DB05910 description "ALS-357 is a novel drug entering phase I/II clinical development that has demonstrated potent anti-tumor activity against malignant melanoma. ALS-357 has shown promise in both in vitro and in vivo preclinical studies. Rapid tumor regression has been shown in a mouse model and no observable toxicity was seen even at high doses." assertion.
- drugbank:DB05910 identifier "drugbank:DB05910" assertion.
- drugbank:DB05910 title "ALS-357" assertion.
- drugbank:DB05910 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05910 drugbank_vocabulary:drugbank-id "DB05910" assertion.
- drugbank:DB05910 bio2rdf_vocabulary:x-identifiers.org DB05910 assertion.
- drugbank:DB05910 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05910" assertion.
- drugbank:DB05910 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05910 bio2rdf_vocabulary:identifier "DB05910" assertion.